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Purpose/Objective: This study evaluated a number of 
commercial auto-segmentation algorithms and quantified 
their accuracy compared to inter-observer variability to 
identify their suitability for clinical use without or with 
minimal manual intervention. 
Materials and Methods: 12 head-and-neck (H&N) and 12 
prostate patient CT scans, delineated by experienced 
consultants for clinical use, were selected as gold-standard 
cases. Outlines for brain, brainstem, spinal cord, mandible, 
and parotids in H&N cases and bladder, prostate, rectum, 
seminal vesicles and femoral heads in prostate cases were 
automatically generated by several algorithms: 
- OnQ rts atlas-based segmentation (ABS); with user defined 
atlases 
- RayStation ABS; with user defined atlases 
- RayStation model-based segmentation (MBS) 
- Pinnacle smart probabilistic image contouring engine 
(SPICE) 
- MultiPlan AutoSegment semi-automatic MBS; requires user 
to manually define initialisation points (pelvis only) 
The datasets were also manually re-contoured by two 
additional observers (consultant, registrars or specialist 
radiographer) to quantify inter-observer variation. All 
contours were quantitatively compared against the reference 
contours using the mean distance to conformity (MDC) and 
DICE similarity coefficient (DSC): 
 
 
where VA is the evaluated volume and VR the reference 
volume. DSC can take values between 0 and 1 with 1 
revealing perfect overlap while 0 no overlap between the two 
contours. MDC is defined as the average distance that all 
outlying points in VA must be moved to achieve perfect 
conformity with VR and is measured in units of distance (i.e. 
mm). 
Results: Figure 1 shows representative examples of slice-wise 
MDC uncertainties observed in the H&N region. The evaluated 
algorithms performed better in structures with bony anatomy 
or high contrast to surrounding tissue (e.g. median MDC range 
of 1.4-1.7mm for spinal cord) and less well in soft tissue and 
low contrast regions (e.g. median MDC range of 2.8-3.5mm 
for parotids), with substantial errors occasionally observed 
(e.g. lowest decile MDC range of 6.0-14.6mm for parotids). In 
the male pelvis region MBS algorithms performed better than 
ABS algorithms as demonstrated by the mean DSC results in 
Table 1. Although some algorithms performed comparably 
with inter-observer variability in 90% of the examined CT 
slices, in both H&N and prostate anatomies, the input of an 
expert observer is still generally warranted. It should be 
noted that within the lowest decile (not shown in Fig. 1) all 
algorithms deviated substantially beyond the range of inter-
observer variability. 
 
 
 
 
Conclusions: The performance of the tested algorithms was 
inferior to inter-observer variability in both H&N and prostate 
anatomies, and would need evaluation and corrections before 
contours could be used clinically. Certain algorithms, 
however, exposed comparable uncertainties to inter-observer 
variability and would only require minor manual corrections. 
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Purpose/Objective: Stereotactic radiotherapy requires exact 
knowledge of the tumor position to achieve a high dose 
delivery to the treatment volume. Pancreatic tumors show a 
large breathing induced motion up to 3 cm or more. Different 
motion management strategies are available in order to 
obtain smaller treatment margins, for example abdominal 
compression or gated radiotherapy. In this study, we explore 
the effect of a custom abdominal corset on pancreatic tumor 
motion with cine MRI.  
Materials and Methods: Ten patients with unresectable 
pancreatic cancer scheduled for stereotactic radiotherapy 
were included in this study. For all patients, a custom 
abdominal corset was manufactured (Neofrakt®, Spronken 
Orthopedie NV, Genk, Belgium. Figure 1A). All patients were 
scanned twice on a 1.5T scanner (Achieva, Philips, Best, The 
Netherlands); once without the corset, and once with the 
corset in place. The corset was tightened to the patient in a 
way that it was tight but still reasonable comfortable. Each 
scan session included one sagittal and one coronal cine MRI 
scan with a T2/T1 weighted contrast (bSSFP) localised 
through the center of the tumor (Figure 1B). Image 
parameters: frame rate = 2 Hz, slice thickness = 7 mm, scan 
duration = 1 minute. Tumor tracking was performed with a 
Minimum Output Sum of Squared Error (MOSSE) adaptive 
correlation filter, which enables real-time tracking of a 
moving object. Motion in each direction was reported as the 
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100% and 95% motion, where 100% is the peak-to-peak 
motion. The 95% is defined as the bandwidth that includes 
95% of the data points but excludes the 5th percentile most 
extreme data points. 
Results: The two MRI scans were obtained with a mean 
interval of 16 days (range 0-37 days). All patients tolerated 
the corset well during MRI scanning and radiotherapy. Motion 
characteristics are described in Table 1. Peak-to-peak motion 
without corset in craniocaudal direction was on average 11.3 
mm, with a maximum amplitude of 22.1 mm. With the 
application of the corset, the average 100% craniocaudal 
motion was 7.3 mm (maximum amplitude 13.4 mm). The 
largest decrease in 100% motion was seen in craniocaudal 
direction, with an average reduction of 4.1 mm. In lateral 
direction, a decrease in 100% motion of 0.4 mm was 
observed. In anteroposterior direction, no motion reduction 
was seen. The largest motion reduction achieved in one 
patient was a 100% motion of 22.1 mm without corset; with 
the corset this was 4.9 mm. A typical example of tumor 
motion pattern with and without corset is shown in Figure 1C.  
 
 
 
Conclusions: Substantial pancreatic tumor motion decrease 
was observed with the use of a custom abdominal corset. As 
a result, treatment margin reduction is possible for 
stereotactic radiotherapy in free breathing conditions with 
maintained patient comfort. This in turn offers opportunities 
for dose escalation without increasing toxicity. 
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Purpose/Objective: MLC tracking is a promising method for 
real-time target motion compensation by continuous 
adaptation of the MLC aperture to a moving target. A number 
of studies with proto-type MLC tracking systems have 
demonstrated the ability to mitigate motion-induced dose 
errors, and a non-commercial system is currently used in a 
clinical study of prostate cancer. However, to get MLC 
tracking into routine clinical practice at a larger scale a more 
integrated system is needed. This study provides the first 
characterization of the prototype MLC tracking system 
included in the research part of the Varian TrueBeam 2.0 
accelerator. 
Materials and Methods: Several experiments were performed 
to characterize the performance of Calypso-guided MLC 
tracking on a TrueBeam linear accelerator. The MLC tracking 
system latency was determined as the time lag between 
sinusoidal target motion and the center of a circular beam as 
recorded by continuous MV portal imaging during MLC 
tracking with prediction turned off. Normally, the jaws also 
follow the target just outside the MLC aperture. The tracking 
latency of the backup jaws was determined similarly in portal 
images by tracking a rectangular field formed by the jaws 
alone. The geometric tracking accuracy was determined as 
the 2D distance in portal images between a target following 
eight representative trajectories (prostate and lung) and the 
